MOTAVIZUMAB
UNII 50Y163LK8Q

Substance Identification & Data

This profile provides standardized clinical and technical data for Motavizumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 50Y163LK8Q.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 677010-34-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

50Y163LK8Q

CAS Registry Number

677010-34-3

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

MOTAVIZUMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C88584

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

22023143

Unique identification number in the NCBI database of chemical substances.

INN ID

8693

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

RR-22

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Motavizumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

MOTAVIZUMAB

Common Names & Synonyms

IMMUNOGLOBULIN G1, ANTI-(RESPIRATORY SYNCYTIAL VIRUS GLOCOPROTEIN F) (HUMAN-MOUSE MONOCLONAL MEDI-524 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL MEDI-524.KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G1, ANTI-(RESPIRATORY SYNCYTIAL VIRUS GLOCOPROTEIN F) (HUMAN-MOUSE MONOCLONAL MEDI-524 .GAMMA.1-CHAIN), DISULPHIDE WITH HUMAN-MOUSE MONOCLONAL MEDI-524.KAPPA.-CHAIN, DIMER

MOTAVIZUMAB [INN]

MOTAVIZUMAB [USAN]

MOTAVIZUMAB [WHO-DD]